Elicio Therapeutics ELTX
NASDAQ ELTX
$1.67 +0.10 (+6.37%)
At close: Oct 21, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) EBITDA Margin (2020 - 2024)

Updated

Elicio Therapeutics (ELTX) recorded EBITDA Margin of -1014.04% in FY2022, down 875.56 percentage points from -138.48% in FY2021.

Analysis

Elicio Therapeutics (ELTX) EBITDA Margin (2020 - 2024) Analysis & Trends

  • Per Business Quant data, ELTX's EBITDA Margin was -138.48% in FY2021 (+1777.25 pp) and -1915.73% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 35.95%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 49.01%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.11%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -124.26%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 39.16%
10 Elicio Therapeutics 31.85 Mn -45.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -6,760.67%
Dec 31, 2023 -12,392.00%
Sep 30, 2023 -4,378.46%
Jun 30, 2023 -19,674.36%
Jun 30, 2022 -930.78%
Mar 31, 2022 -877.00%
Dec 31, 2021 56.57%
Sep 30, 2021 -1,077.74%
Jun 30, 2021 -3,374.26%
Mar 31, 2021 -4,864.96%
Dec 31, 2020 -1,942.27%
Sep 30, 2020 -1,130.71%
Jun 30, 2020 -2,308.09%
Mar 31, 2020 -1,431.79%
API Access

Elicio Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ELTX&period=max&api_key=YOUR_API_KEY